Boogerd W - Search Results

1

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.

Kerst JM, Bex A, Mallo H, Dewit L, Haanen JB, Boogerd W, Teertstra HJ, de Gast GC. Kerst JM, et al. Among authors: boogerd w. Cancer Immunol Immunother. 2005 Sep;54(9):926-31. doi: 10.1007/s00262-005-0677-2. Epub 2005 May 19. Cancer Immunol Immunother. 2005. PMID: 15906025 Free PMC article. Clinical Trial.

2

Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?

Boogerd W, de Gast GC, Dalesio O. Boogerd W, et al. Cancer. 2007 Jan 15;109(2):306-12. doi: 10.1002/cncr.22411. Cancer. 2007. PMID: 17149755 Free article.

3

Response of leptomeningeal metastases from breast cancer to hormonal therapy.

Boogerd W, Dorresteijn LD, van Der Sande JJ, de Gast GC, Bruning PF. Boogerd W, et al. Neurology. 2000 Jul 12;55(1):117-9. doi: 10.1212/wnl.55.1.117. Neurology. 2000. PMID: 10891918

4

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma.

de Gast GC, Batchelor D, Kersten MJ, Vyth-Dreese FA, Sein J, van de Kasteele WF, Nooijen WJ, Nieweg OE, de Waal MA, Boogerd W. de Gast GC, et al. Among authors: boogerd w. Br J Cancer. 2003 Jan 27;88(2):175-80. doi: 10.1038/sj.bjc.6600717. Br J Cancer. 2003. PMID: 12610499 Free PMC article.

5

Outcome of patients with primary central nervous system lymphoma treated outside clinical trials.

Hart A, Baars JW, Kersten MJ, Brandsma D, van Tinteren H, de Jong D, Spiering M, Dewit L, Boogerd W. Hart A, et al. Among authors: boogerd w. Neth J Med. 2014 May;72(4):218-23. Neth J Med. 2014. PMID: 24829178 Free article.

6

Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma.

Geukes Foppen MH, Brandsma D, Blank CU, van Thienen JV, Haanen JB, Boogerd W. Geukes Foppen MH, et al. Among authors: boogerd w. Ann Oncol. 2016 Jun;27(6):1138-1142. doi: 10.1093/annonc/mdw134. Epub 2016 Mar 8. Ann Oncol. 2016. PMID: 26961150 Free article.

7

Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma.

Geukes Foppen MH, Boogerd W, Blank CU, van Thienen JV, Haanen JB, Brandsma D. Geukes Foppen MH, et al. Among authors: boogerd w. Melanoma Res. 2018 Apr;28(2):126-133. doi: 10.1097/CMR.0000000000000429. Melanoma Res. 2018. PMID: 29356790

8

Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer.

Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Kerst JM, Kirschbaum C, Reneman L, Schagen SB. Stouten-Kemperman MM, et al. Among authors: boogerd w. Brain Connect. 2018 Sep;8(7):398-406. doi: 10.1089/brain.2017.0569. Epub 2018 Sep 6. Brain Connect. 2018. PMID: 29999422

9

Response of brain metastases from breast cancer to systemic chemotherapy.

Boogerd W, Dalesio O, Bais EM, van der Sande JJ. Boogerd W, et al. Cancer. 1992 Feb 15;69(4):972-80. doi: 10.1002/1097-0142(19920215)69:4<972::aid-cncr2820690423>3.0.co;2-p. Cancer. 1992. PMID: 1735089

10

The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.

Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, Hart AA, Benraadt J, Vecht ChJ. Boogerd W, et al. Eur J Cancer. 2004 Dec;40(18):2726-33. doi: 10.1016/j.ejca.2004.08.012. Eur J Cancer. 2004. PMID: 15571954 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters